ADCT News and Press, ADC Therapeutics SA From 12/19/25

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines Canada NewsWire Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC , Dec. 19, 2025 /CNW/ -- Equity Insider News Commentary – The oncology sector's pivot toward platf...

2025-12-03 15:06:29 ET Gregory Renza from RBC Capital issued a price target of $5.00 for ADCT on 2025-12-03 18:43:00. The adjusted price target was set to $5.00. At the time of the announcement, ADCT was trading at $3.955. The overall price target consensus is at $10.00 ...

2025-12-03 14:15:07 ET RBC Capital analyst issues OUTPERFORM recommendation for ADCT on December 3, 2025 06:43PM ET. The previous analyst recommendation was Outperform. ADCT was trading at $3.505 at issue of the analyst recommendation. The overall analyst consensus : BUY...

2025-12-03 10:53:25 ET ADC Therapeutics SA (ADCT) Discusses Updated Results From LOTIS-7 Trial Evaluating ZYNLONTA Plus Glofitamab in Relapsed or Refractory DLBCL December 3, 2025 8:00 AM EST... Read the full article on Seeking Alpha For further details see: ADC Therapeutics...

ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma PR Newswire ZYNLONTA® in combina...

ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial PR Newswire Company to host corporate webcast to share updated data on December 3, 2025 LAUSANNE, Switzerland , Dec. 2, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader a...

2025-11-10 11:23:46 ET More on ADC Therapeutics ADC Therapeutics SA (ADCT) Q3 2025 Earnings Call Transcript ADC Therapeutics SA 2025 Q3 - Results - Earnings Call Presentation ADC Therapeutics SA 2025 Q2 - Results - Earnings Call Presentation ADC Therapeutics ...

2025-11-10 11:21:30 ET ADC Therapeutics SA (ADCT) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Nicole Riley Ameet Mallik - CEO & Director Mohamed Zaki - Chief Medical Officer Jose Carmona - Chief Financial Officer ... ...

2025-11-10 07:36:31 ET More on ADC Therapeutics ADC Therapeutics SA 2025 Q2 - Results - Earnings Call Presentation ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Transcript ADC Therapeutics Q3 Earnings Preview ADC Therapeutics rises on $60M PIPE financing ...

ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update PR Newswire Continued progress across LOTIS-7 with updated data anticipated in 2025 and LOTIS-5 with topline data expected in 1H 2026 Updated data from Phase 2 IIT of ZYNLONTA ...